Longitudinal dynamics of frailty in older people: Trajectories, transitions and associated clinical factors.

Authors

Dolores Mino-León, Abigail Vanessa Rojas-Huerta, Giancarlo Roach-Rivas, Sergio Sánchez-García, Hortensia Reyes-Morales

Published in

Archives of gerontology and geriatrics. Volume 151. Pages 106388. Aug 26, 2026. Epub Aug 26, 2026.

Abstract

Frailty is a dynamic geriatric syndrome characterized by progressive deterioration related to age.
To describe the trajectories and estimate the transition probabilities between frailty phenotypes and identify clinical variables and drugs associated with the transition to more severe phenotypes over four years of follow-up in a cohort of elderly people living in the community.
Secondary analysis of data from the study "Cohort of Obesity, Sarcopenia and Frailty of Older Mexican Adults". The baseline sample included adults ≥ 60 years, with annual monitoring for four years.
Frailty phenotype, chronic diseases, multimorbidity, medications, polypharmacy, and sociodemographic variables. The trajectories were identified using the optimal alignment algorithm, and the longitudinal patterns of fragility were analyzed with hierarchical clustering techniques. The annual transition probabilities were estimated with a nested Markov model, and the factors associated with the transitions were identified using ordinal multilevel mixed-effects logistic regression models.
The initial cohort included 973 patients. Four frailty trajectories were identified. The transitions between frailty phenotypes were asymmetric, and the lowest annual rate of occurrence was improvement. The effect of time (follow-up), each additional year of a person, being female, suffering from multimorbidity (MM) and receiving antihypertensive, psycholeptic and/or psychoanaleptic, antiparkinsonian, or antivertiginous drugs increased the probability of moving toward a more severe state of frailty; a higher level of education and having a partner conferred a protective effect.
Early identification of the prefrailty condition offers a window of opportunity to reverse it or prevent further deterioration.

PMID:
42669283
Bibliographic data and abstract were imported from PubMed on 31 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.